VI 25 mcg OD (n = 101) | SAL 50 mcg BD (n = 100) | Placebo (n = 95) | |
---|---|---|---|
Germany (N = 28) | 62 (127.6) | 175 (156.2) | 19 (221.6) |
Peru (N = 104) | 391 (433.8) | 360 (364.7) | 492 (591.9) |
Poland (N = 59) | 279 (310.4) | 251 (513.9) | 117 (615.6) |
Ukraine (N = 43) | 158 (238.7) | 127 (198.5) | 200 (253.9) |
United States (N = 62) | 519 (568.2) | 392 (756.0) | 400 (522.5) |